Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a (8) Sgb V On Medicines Containing The Active Ingredient Ivabradine (atc: C01eb17) Within The Framework Of A So-called Open-house Model.
Contract notice: Conclusion of non-exclusive discount agreements pursuant to section 130a (8) sgb v on medicines containing the active ingredient ivabradine (atc: C01eb17) within the framework of a so-called open-house model.
For the active ingredient ivabradine, The aok rheinland-pfalz / saarland - die gesundheitskasse offers discount agreements to all interested pharmaceutical companies for the period until the entry into force of exclusive contracts following a formal award procedure in accordance with the provisions of part 4 of the gwb. The contracts are concluded as part of a so-called "open-house model". The contracts offered are not exclusive. In the open-house model, Uniform conditions apply to all participants. Contract contents, Conditions and access procedures are uniform, Individual negotiations are generally not conducted. The contract terms are a maximum of twenty-four months, The earliest date of contract is 1.5.2018. All contracts end at the latest on 30.4.2020, Regardless of the date of the respective contract. An accession or a contract can be made at any time and under the same conditions. There is a right of termination six weeks to the end of the month. The aok rhineland-palatinate / saarland - the health fund reserves the right to replace during the contract period, The non-exclusive open-house discount agreements by exclusive discount agreements. With the entry into force of exclusive, Exclusive discount agreements, The open-house contracts will be terminated in accordance with the contractual provisions. Interested pharmaceutical companies can request the participation documents as well as the contract documents at the contact address named under i.1). Contracts for the active ingredient ivabradine (atc: C01eb17) will be concluded for the first time with effect from 1.5.2018. Interested parties wishing to become contract partners on this date must submit the contract documents to be submitted by 31.3.2018 at the address specified in the contract documents. It depends on the access to the aok rhineland-palatinate / saarland. Note: The first award in this procedure will be issued no earlier than 10 calendar days after the publication of this eu notice in the official journal. Subsequent contracts are possible during the 24-month maximum term on the first of each month. Interested parties wishing to become parties to these follow-up appointments must submit the contract documents including annex 1 at the latest by the end of the month preceding the month of the desired contract start (eg receipt 30.04., At the start of the contract 01.06.). The exact deadlines are announced with the contract documents. This publication is not a public contract within the meaning of the 2014/24 / eu procurement coordination directive of the european parliament and of the council or of the public procurement law. In order to ensure the widest
Major organization : AOK RHEINLAND-PFALZ/SAARLAND DIE GESUNDHEITSKASSE
Address : Virchowstrae 30
Email : firstname.lastname@example.org
Address : Www.Aok.De/Rheinland-Pfalz-Saarland/
Tender notice number : 110177-2018
Notice type : Tender Notice
Open date : 2020-02-29
Tender documents : T432949192.html
[c] 2018 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. ( Syndigate.info ).
|Printer friendly Cite/link Email Feedback|
|Date:||Mar 13, 2018|
|Previous Article:||Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a (8) Sgb V On Medicines Containing The Active Substance Aprepitant,...|
|Next Article:||University Of Bonn, Schloss Poppelsdorf, Roof And Facade Renovation, Plaster, Stucco And Painting Work.|